SCHEMBL3930561

SCHEMBL3930561

COc1ccccc1CN1C(=O)c2ccccc2C1C(=O)Nc1c(Cl)cccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.54
NPSR1 Q6W5P4 5/20 0.53
ALDH1A1 P00352 4/20 0.53
TSHR P16473 1/20 0.53
LMNA P02545 2/20 0.52
THRB P10828 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
F2 P00734 1/20 0.52
MAPT P10636 3/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
HPGD P15428 1/20 0.51
MAPK1 P28482 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
KCNA5 P22460 2/20 0.49
KCNH2 Q12809 2/20 0.49
RECQL P46063 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3937415 0.94 TP53 (0.51) TP53NPSR1ALDH1A1TSHRLMNA
SCHEMBL4008342 0.92 ALDH1A1 (0.56) TP53NPSR1ALDH1A1TSHRLMNA
SCHEMBL3930978 0.90 KCNA5 (0.49) TP53NPSR1ALDH1A1TSHRLMNA
SCHEMBL3934300 0.89 ALDH1A1 (0.54) TP53NPSR1ALDH1A1TSHRLMNA
SCHEMBL4363829 0.84 ALDH1A1 (0.54) NPSR1ALDH1A1TSHRLMNATHRB
SCHEMBL3754130 0.81 KCNA5 (0.73) NPSR1ALDH1A1TSHRLMNATHRB
SCHEMBL3932445 0.81 ALDH1A1 (0.56) TP53NPSR1ALDH1A1TSHRLMNA
SCHEMBL4164264 0.80 KCNA5 (0.56) TP53NPSR1ALDH1A1TSHRLMNA
SCHEMBL4159090 0.80 KCNA5 (0.53) ALDH1A1LMNATHRBSMN1; SMN2F2
SCHEMBL3750006 0.80 ALDH1A1 (0.66) TP53NPSR1ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents ASTRAZENECA AB (SE) 2009-11-26 US claimed
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents ASTRAZENECA AB (SE) 2009-11-26 US disclosed
EP-2044019-A1 3-OXOISOINDOLINE-1-CARBOXAMIDE DERIVATIVES AS ANALGESIC AGENTS Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008008020-A1 3-OXOISOINDOLINE-1-CARBOXAMIDE DERIVATIVES AS ANALGESIC AGENTS ASTRAZENECA AB (SE) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291983-A1 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents OPRD1, OPRK1, OPRM1 TP53 4703/4885NPSR1 66/4885ALDH1A1 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.